Ankara Etlik City Hospital
Ankara, Yenimahalle\Ankara, 06170, Turkey (Türkiye)
Location status: Recruiting
Location contact
Musa Assoc.Prof Zengin
CONTACT
İbrahim MD Topcu
CONTACT
NCT Number: NCT07609680
This prospective randomized trial aims to compare the effects of two intraoperative hemodynamic management strategies on early postoperative renal function in patients undergoing colorectal surgery. Patients will be randomly assigned to receive either mean arterial pressure-guided or cardiac index-guided intraoperative hemodynamic management.
Colorectal surgery is a major abdominal procedure associated with prolonged operative times, significant fluid shifts, blood loss, and hemodynamic instability. These factors can contribute to impaired renal perfusion and subsequent postoperative renal dysfunction. Although mean arterial pressure is widely used to guide intraoperative hemodynamic management, blood pressure alone may not adequately reflect systemic blood flow or regional tissue perfusion. Cardiac index-guided management may provide a more direct assessment of global circulatory adequacy.
The primary outcome of the study is the change in serum creatinine levels from the preoperative baseline to 72 hours postoperatively. Secondary outcomes include intraoperative hemodynamic variables, fluid and vasopressor requirements, urine output, postoperative renal function parameters, intensive care unit (ICU) and hospital length of stay, and 30-day mortality.
Interested in participating?
Request Info18 year–80 year
All sexes
Interventional
Not applicable
Ankara, Yenimahalle\Ankara, 06170, Turkey (Türkiye)
Location status: Recruiting
Musa Assoc.Prof Zengin
CONTACT
İbrahim MD Topcu
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intraoperative hemodynamic management will be performed according to predefined mean arterial pressure targets during colorectal surgery. Standard anesthetic care, fluid therapy, vasopressor use, and intraoperative monitoring will be applied according to institutional clinical practice.
Intraoperative hemodynamic management will be performed according to predefined cardiac index targets during colorectal surgery. Cardiac index values will be monitored intraoperatively, and fluid therapy, vasopressor use, and inotrope administration will be adjusted according to the hemodynamic status of the patient and institutional clinical practice.
Time frame: : Preoperative baseline and postoperative 72nd hour
The primary outcome is the change in serum creatinine level, calculated as the difference between the serum creatinine value measured at postoperative 72 hours and the preoperative baseline serum creatinine value.
Time frame: From anesthesia induction to the end of surgery
Hourly urine output will be recorded intraoperatively and expressed as mL/kg/hour.
Time frame: From anesthesia induction to the end of surgery
The total amount of crystalloid and colloid fluids administered intraoperatively will be recorded.
Time frame: Postoperative 0-6 hours, 24 hours, 48 hours, and 72 hours
Serum creatinine values will be recorded at predefined postoperative time points to evaluate renal function trends during the early postoperative period.
Contact information is provided by the study sponsor or research team.
Musa Ass. Prof Zengin
CONTACT
İbrahim MD Topcu
CONTACT
Ankara Etlik City Hospital
Other Gov
Comparison of the Effects of Mean Arterial Pressure-Based and Cardiac Index-Based Intraoperative Hemodynamic Management on Postoperative Renal Function in Patients Undergoing Colorectal Surgery: A Prospective Randomized Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07736495
Colonic Diseases, Colorectal Cancer
Cairo, Egypt
View Trial DetailsNCT06411691
Colonic Diseases, Colonic Neoplasms
Baltimore, Maryland, United States
View Trial DetailsNCT07321106
Advanced Colorectal Cancer, CRC
Duarte, California, United States
View Trial DetailsNCT04847063
Abdominal Neoplasms, Adnexal Diseases
Bethesda, Maryland, United States
View Trial Details